DrugPatentWatch Database Preview
Kadmon Pharms Llc Company Profile
What is the competitive landscape for KADMON PHARMS LLC, and what generic and branded alternatives to KADMON PHARMS LLC drugs are available?
KADMON PHARMS LLC has four approved drugs.
Summary for Kadmon Pharms Llc
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 2 |
| NDAs: | 4 |
Drugs and US Patents for Kadmon Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kadmon Pharms Llc | RIBAVIRIN | ribavirin | TABLET;ORAL | 077456-002 | Dec 5, 2005 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Kadmon Pharms Llc | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 209415-001 | Sep 16, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Kadmon Pharms Llc | RIBAVIRIN | ribavirin | TABLET;ORAL | 077456-003 | Dec 5, 2005 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
